Correlation Between Inovio Pharmaceuticals and Mustang Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inovio Pharmaceuticals and Mustang Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inovio Pharmaceuticals and Mustang Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inovio Pharmaceuticals and Mustang Bio, you can compare the effects of market volatilities on Inovio Pharmaceuticals and Mustang Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inovio Pharmaceuticals with a short position of Mustang Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inovio Pharmaceuticals and Mustang Bio.

Diversification Opportunities for Inovio Pharmaceuticals and Mustang Bio

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Inovio and Mustang is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and Mustang Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mustang Bio and Inovio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inovio Pharmaceuticals are associated (or correlated) with Mustang Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mustang Bio has no effect on the direction of Inovio Pharmaceuticals i.e., Inovio Pharmaceuticals and Mustang Bio go up and down completely randomly.

Pair Corralation between Inovio Pharmaceuticals and Mustang Bio

Considering the 90-day investment horizon Inovio Pharmaceuticals is expected to under-perform the Mustang Bio. But the stock apears to be less risky and, when comparing its historical volatility, Inovio Pharmaceuticals is 1.93 times less risky than Mustang Bio. The stock trades about -0.19 of its potential returns per unit of risk. The Mustang Bio is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest  28.00  in Mustang Bio on September 6, 2024 and sell it today you would lose (9.00) from holding Mustang Bio or give up 32.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.44%
ValuesDaily Returns

Inovio Pharmaceuticals  vs.  Mustang Bio

 Performance 
       Timeline  
Inovio Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inovio Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Mustang Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mustang Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Inovio Pharmaceuticals and Mustang Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inovio Pharmaceuticals and Mustang Bio

The main advantage of trading using opposite Inovio Pharmaceuticals and Mustang Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inovio Pharmaceuticals position performs unexpectedly, Mustang Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will offset losses from the drop in Mustang Bio's long position.
The idea behind Inovio Pharmaceuticals and Mustang Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios